Anmeldung erfolgt in Kürze...
Details werden geladen...
Immunotherapy Combo Improves Bladder Cancer EFS
The phase 3 VOLGA trial looks at perioperative durvalumab plus enfortumab vedotin, with and without tremelimumab, for muscle-invasive bladder cancer.
Ähnliche Seiten
Personalized Melanoma Vaccine Improves RFS in Phase 3 Trial
https://www.medscape.com/viewarticle/personalized-melanoma-vaccine-improves-recurrence-free-2026a100148eTarlatamab Maintenance Combo Boosts Lung Cancer Survival
https://www.medscape.com/viewarticle/tarlatamab-maintenance-therapy-combo-boosts-lung-cancer-2026a100148uHealthy Lifestyle Tied to Better Health After Breast Cancer
https://www.medscape.com/viewarticle/higher-alignment-lifestyle-guidelines-linked-better-physical-2026a10012qgDo Industry Payments Influence End-of-Life Cancer Care?
https://www.medscape.com/viewarticle/do-industry-payments-influence-end-life-cancer-care-2026a10013yrHow Scientists Finally Cracked RAS in Pancreatic Cancer
https://www.medscape.com/viewarticle/how-scientists-finally-cracked-ras-pancreatic-cancer-2026a10010ok